Wei Ru (维如)维如
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 国营张家港市制药厂Chinese legal name: 国营张家港市制药厂
主要成分Active Ingredients
- 更昔洛韦Gengxi Luowei
- 化学名Huaxue Ming
药物知识说明
更昔洛韦是一种在国家药监局注册认定的药品。该药品含有更昔洛韦-9027acad等成分。
该药品关联的活性成分包括：更昔洛韦Gengxi Luowei。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：国营张家港市制药厂Chinese legal name: 国营张家港市制药厂。
您可以探索含有相同成分的其他药品：更昔洛韦-9027acad成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 维如) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 更昔洛韦Gengxi Luowei.
Manufacturers recorded for this product: 国营张家港市制药厂Chinese legal name: 国营张家港市制药厂.
Explore other medicines containing the same ingredient: 更昔洛韦 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 维如Recorded Chinese name: 维如
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 100ml:更昔洛韦钠(以更昔洛韦计)0.25g与氯化钠0.9gRecorded Chinese specification: 100ml:更昔洛韦钠(以更昔洛韦计)0.25g与氯化钠0.9g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 国营张家港市制药厂Chinese legal name: 国营张家港市制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20060126
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20060126
Manufacturer
Chinese legal name: 国营张家港市制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20060126
生产企业
国营张家港市制药厂(国产)
适应症
1.预防可能发生于有巨细胞病毒感染风险的器官移植受者的巨细胞病毒病。|2.治疗免疫功能缺陷患者（包括艾滋病患者）发生的巨细胞病毒性视网膜炎。
用法用量
1.诱导期：静脉滴注按体重一次5mg/kg，每12小时1次，每次静滴1小时以上，疗程14～21日，肾功能减退者剂量应酌减。肌酐清除率为50～69ml/分钟时，每12小时静脉滴注2.5mg/kg；肌酐清除率为25～49ml/分钟时，每24小时静脉滴注2.5mg/kg；肌酐清除率为10～24ml/分钟时，每24小时静脉滴注1.25mg/kg；肌酐清除率＜10ml/分钟时，每周给药3次，每次1.25mg/kg于血液透析后给予。|2.维持期：静脉滴注按体重一次5mg/kg，一日1次，静滴1小时以上。肾功能减退者按肌酐清除率调整剂量：肌酐清除率为50～69ml/分钟时，每24小时静脉滴注2.5mg/kg；肌酐清除率为25～49ml/分钟时，每24小时静脉滴注1.25mg/kg；肌酐清除率为10～24ml/分钟时，每24小时静脉滴注0.625mg/kg；肌酐清除率＜10ml/分钟时，每周给药3次，每次0.625mg/kg于血液透析后给予。|3.预防用药：静脉滴注按体重一次5mg/kg，滴注时间至少1小时以上，每12小时1次，连续7～14日；继以5mg/Kg，一日1次，共7日。
不良反应
1.本品可引起粒细胞减少、中性白细胞减少及血小板减少。罕见：头痛、头昏、呼吸困难、恶心、呕吐、腹痛、腹泻、厌食、消化道出血、心律失常、血压升高或血压降低、寒战、血尿素氮增加、脱发、瘙痒、荨麻疹、血糖降低、浮肿、周身不适、肌酐增加、嗜伊红细胞增多症等。|2.有巨细胞病毒感染性视网膜炎的艾滋病患者可出现视网膜剥离。
禁忌
对更昔洛韦或阿昔洛韦过敏者禁用。
注意事项
1.一次最大剂量为6mg/kg，充分溶解后，缓慢静滴。溶液呈强碱性，故滴注时间不得少于1小时，避免与皮肤、粘膜接触，避免液体渗漏到血管外组织。|2.白细胞计数低于500/mm3或血小板计数低于25，000/mm3患者慎用。|3.肾功能损害患者慎用。
贮藏
遮光，密封保存。
规格
100ml:更昔洛韦钠(以更昔洛韦计)0.25g与氯化钠0.9g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.